{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:52:26Z","timestamp":1793105546688,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL131745"],"award-info":[{"award-number":["R01HL131745"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL136681"],"award-info":[{"award-number":["R01HL136681"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL140357"],"award-info":[{"award-number":["R01HL140357"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL142049"],"award-info":[{"award-number":["R01HL142049"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R13HL142300"],"award-info":[{"award-number":["R13HL142300"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001465","name":"American Thoracic Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014933","name":"aTyr Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014933","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.chest.2022.10.037","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T20:36:45Z","timestamp":1667853405000},"page":"881-890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Efzofitimod for the Treatment of Pulmonary Sarcoidosis"],"prefix":"10.1016","volume":"163","author":[{"given":"Daniel A.","family":"Culver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3753-4378","authenticated-orcid":false,"given":"Shambhu","family":"Aryal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Barney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie C.W.","family":"Hsia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4944-1627","authenticated-orcid":false,"given":"W. Ennis","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3210-8051","authenticated-orcid":false,"given":"Lucian T.","family":"Marts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4692-1345","authenticated-orcid":false,"given":"Ogugua Ndili","family":"Obi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1006-9437","authenticated-orcid":false,"given":"Peter H.S.","family":"Sporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadera J.","family":"Sweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7162-8677","authenticated-orcid":false,"given":"Nelson","family":"Kinnersley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4415-2191","authenticated-orcid":false,"given":"Gennyne","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Baughman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chest.2022.10.037_bib1","doi-asserted-by":"crossref","first-page":"l5553","DOI":"10.1136\/bmj.l5553","article-title":"New advances in the management of pulmonary sarcoidosis","volume":"367","author":"Culver","year":"2019","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.chest.2022.10.037_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.chest.2022.10.037_bib3","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2213-2600(21)00311-8","article-title":"Misconceptions regarding symptoms of sarcoidosis","volume":"9","author":"Drent","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"7","key":"10.1016\/j.chest.2022.10.037_bib4","first-page":"967","article-title":"Management of chronic respiratory failure in interstitial lung diseases: overview and clinical insights","volume":"16","author":"Faverio","year":"2019","journal-title":"Int J Med"},{"issue":"5","key":"10.1016\/j.chest.2022.10.037_bib5","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.rmed.2009.12.009","article-title":"Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study","volume":"104","author":"Schutt","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.chest.2022.10.037_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rmed.2017.09.003","article-title":"Toxicity risk from glucocorticoids in sarcoidosis patients","volume":"132","author":"Khan","year":"2017","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.chest.2022.10.037_bib7","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1378\/chest.125.3.997","article-title":"Health-related quality of life in persons with sarcoidosis","volume":"125","author":"Cox","year":"2004","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.chest.2022.10.037_bib8","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.rmed.2012.01.013","article-title":"The treatment of pulmonary sarcoidosis","volume":"106","author":"Judson","year":"2012","journal-title":"Respir Med"},{"issue":"28","key":"10.1016\/j.chest.2022.10.037_bib9","doi-asserted-by":"crossref","first-page":"19269","DOI":"10.1074\/jbc.C114.571026","article-title":"Secreted histidyl-tRNA synthetase splice variants elaborate major epitopes for autoantibodies in inflammatory myositis","volume":"289","author":"Zhou","year":"2014","journal-title":"J\u00a0Biol Chem"},{"issue":"6194","key":"10.1016\/j.chest.2022.10.037_bib10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1126\/science.1252943","article-title":"Human tRNA synthetase catalytic nulls with diverse functions","volume":"345","author":"Lo","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.chest.2022.10.037_bib11","first-page":"A3074","article-title":"ATYR1923 specifically binds to neuropilin-2, a novel therapeutic target for the treatment of immune-mediated diseases [abstract]","volume":"201","author":"Xu","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2022.10.037_bib12","doi-asserted-by":"crossref","first-page":"L202","DOI":"10.1152\/ajplung.00067.2018","article-title":"Neuropilin-2 regulates airway inflammatory responses to inhaled lipopolysaccharide","volume":"315","author":"Immormino","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.chest.2022.10.037_bib13","first-page":"A3099","article-title":"Neuropilin-2, the specific binding partner to ATYR1923, is expressed in sarcoid granulomas and key immune cells [abstract]","volume":"201","author":"Paz","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2022.10.037_bib14","first-page":"A2421","article-title":"ATYR1923 modulates the inflammatory response in experimental models of interstitial lung disease [abstract]","volume":"199","author":"Burkett","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2022.10.037_bib15","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1038\/s41423-019-0331-0","article-title":"Serum-circulating his-tRNA synthetase inhibits organ-targeted immune responses","volume":"18","author":"Adams","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.chest.2022.10.037_bib16","article-title":"ATYR1923 reduces neutrophil Infiltration in an acute lipopolysaccharide (LPS) lung injury model","volume":"B7","author":"Paz","year":"2019","journal-title":"Keystone Symposia Conference"},{"key":"10.1016\/j.chest.2022.10.037_bib17","first-page":"A7068","article-title":"The resokine pathway is implicated in the pathology of interstitial lung disease [abstract]","volume":"195","author":"Nangle","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2022.10.037_bib18","first-page":"A1064","article-title":"Pre-clinical characterization of iMod. Fc, an immune-modulatory therapeutic with potentially broad application in interstitial lung diseases","volume":"197","author":"Ogilvie","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2022.10.037_bib20","first-page":"149","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"7","key":"10.1016\/j.chest.2022.10.037_bib32","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1164\/rccm.201410-1785OC","article-title":"Validation and important differences for the Sarcoidosis Assessment Tool. A new patient-reported outcome measure","volume":"191","author":"Judson","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2022.10.037_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/thoraxjnl-2012-201962","article-title":"The development and validation of the King\u2019s Sarcoidosis Questionnaire for the assessment of health status","volume":"68","author":"Patel","year":"2013","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.chest.2022.10.037_bib22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/thorax.58.4.339","article-title":"Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ)","volume":"58","author":"Birring","year":"2003","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.chest.2022.10.037_bib23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1348\/1359107041557048","article-title":"Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS)","volume":"9","author":"De Vries","year":"2004","journal-title":"Br J Health Psychol"},{"issue":"2","key":"10.1016\/j.chest.2022.10.037_bib24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1183\/09031936.03.00068503a","article-title":"Minimal important difference of the transition dyspnoea index in a multinational clinical trial","volume":"21","author":"Witek","year":"2003","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.chest.2022.10.037_bib25","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1183\/09031936.00000914","article-title":"Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis","volume":"44","author":"Judson","year":"2014","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.chest.2022.10.037_bib26","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1378\/chest.111.3.623","article-title":"Outcome in sarcoidosis: the relationship of relapse to corticosteroid therapy","volume":"111","author":"Gottlieb","year":"1997","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2022.10.037_bib27","first-page":"52","article-title":"The late follow-up of chronic sarcoid patients previously treated with corticosteroids","volume":"15","author":"Rizzato","year":"1998","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.chest.2022.10.037_bib28","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1183\/09031936.00060612","article-title":"Established and experimental medical therapy of pulmonary sarcoidosis","volume":"41","author":"Baughman","year":"2013","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.chest.2022.10.037_bib29","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","article-title":"Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement","volume":"174","author":"Baughman","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.chest.2022.10.037_bib30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/thx.51.3.238","article-title":"British Thoracic Society sarcoidosis study: effects of long-term corticosteroid treatment","volume":"51","author":"Gibson","year":"1996","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.chest.2022.10.037_bib31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1378\/chest.121.1.24","article-title":"Early treatment of stage II sarcoidosis improves 5-year pulmonary function","volume":"121","author":"Pietinalho","year":"2002","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2022.10.037_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1183\/23120541.00141-2018","article-title":"Sarcoidosis: patient treatment priorities","volume":"4","author":"Baughman","year":"2018","journal-title":"ERJ Open Res"},{"issue":"9","key":"10.1016\/j.chest.2022.10.037_bib34","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.rmed.2011.05.004","article-title":"Minimal (clinically) important differences for the Fatigue Assessment Scale in sarcoidosis","volume":"105","author":"de Kleijn","year":"2001","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.chest.2022.10.037_bib35","article-title":"Roflumilast (Daliresp\u00ae) to reduce acute pulmonary events in fibrotic sarcoidosis: a multi-center, double blind, placebo controlled, randomized clinical trial","volume":"38","author":"Baughman","year":"2021","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"3","key":"10.1016\/j.chest.2022.10.037_bib36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00408-017-9994-4","article-title":"Repository corticotropin for chronic pulmonary sarcoidosis","volume":"195","author":"Baughman","year":"2017","journal-title":"Lung"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369222040533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369222040533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:49:31Z","timestamp":1757926171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369222040533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0012369222040533"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2022.10.037","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efzofitimod for the Treatment of Pulmonary Sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2022.10.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}